These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35536169)

  • 1. Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Huang PW; Chu CY
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):764. PubMed ID: 35536169
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis.
    Qiumei G; Zhengju C; Xuefei H; Qu C
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
    Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Jee YK; Kim S; Lee JM; Park HS; Kim SH
    Clin Exp Allergy; 2017 Jul; 47(7):972-974. PubMed ID: 28295713
    [No Abstract]   [Full Text] [Related]  

  • 5. Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent.
    Baluch A; Chohan MR; Warda K; Sippy R; Sandhu J
    Cureus; 2022 Feb; 14(2):e21864. PubMed ID: 35155038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
    Jiang YY; Nguyen GH; Jin HZ; Zeng YP
    Int J Dermatol; 2018 Apr; 57(4):494-496. PubMed ID: 29359334
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
    Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
    Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Reactivity Between Carbonic Anhydrase Inhibitor Confirmed by Lymphocyte Transformation Test: A Case of Methazolamide-Induced Toxic Epidermal Necrolysis.
    Sohn KH; Kim SH; Kang HR
    J Investig Allergol Clin Immunol; 2021 Oct; 31(5):455-456. PubMed ID: 33439124
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement.
    Kim S; Yun J; Kang DY; Park HJ; Jo EJ; Jung JW; Park HK; Park JW; Jee YK; Kang HR; Lee JM
    J Allergy Clin Immunol Pract; 2019; 7(8):2851-2853.e2. PubMed ID: 31128378
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of toxic epidermal necrolysis.
    Lee MT; Hung SI; Wei CY; Chen YT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of topical methazolamide ophthalmic solution causing death due to toxic epidermal necrolysis.
    Shi L; Li M; Zhang F; Wang B; Yi X; Ding Y; Wang X
    Clin Exp Dermatol; 2018 Apr; 43(3):326-327. PubMed ID: 29330876
    [No Abstract]   [Full Text] [Related]  

  • 16. Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901.
    Xu Y; Wu M; Sheng F; Sun Q
    Indian J Ophthalmol; 2015 Jul; 63(7):623-4. PubMed ID: 26458485
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
    Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
    Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome induced by methazolamide treatment.
    Shirato S; Kagaya F; Suzuki Y; Joukou S
    Arch Ophthalmol; 1997 Apr; 115(4):550-3. PubMed ID: 9109770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.